# Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care

> **NCT05287022** · — · RECRUITING · sponsor: **Arkansas Children's Hospital Research Institute** · enrollment: 150 (estimated)

## Conditions studied

- Primary Ciliary Dyskinesia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05287022
- **Lead sponsor:** Arkansas Children's Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-06-14
- **Primary completion:** 2030-06
- **Final completion:** 2030-06
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05287022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05287022, "Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05287022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*